These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 6250079

  • 1. Elution of herpes simplex virus-specific cytotoxic antibodies from squamous cell carcinoma of uterine cervix.
    Seth P, Balachandran N.
    Nature; 1980 Aug 07; 286(5773):613-5. PubMed ID: 6250079
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India.
    Seth P, Prakash SS, Ghosh D.
    Int J Cancer; 1978 Dec 07; 22(6):708-14. PubMed ID: 214407
    [Abstract] [Full Text] [Related]

  • 3. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
    Mendis LN, Best JM, Senarath L, Chiphangwi J, Vestergaard BF, Banatvala JE.
    Int J Cancer; 1981 Nov 15; 28(5):535-42. PubMed ID: 6273337
    [Abstract] [Full Text] [Related]

  • 4. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P, Srivatanakul P, Thanapatra S, Kosiyatrakul T, Phitakpraiwan P.
    J Med Assoc Thai; 1980 Oct 15; 63(10):560-7. PubMed ID: 6255050
    [No Abstract] [Full Text] [Related]

  • 5. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
    Christenson B, Espmark A.
    Int J Cancer; 1976 Mar 15; 17(3):318-25. PubMed ID: 176115
    [Abstract] [Full Text] [Related]

  • 6. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M, Georgiou GM, Welsh JK, Cauchi MN, May JT.
    Int J Cancer; 1980 Jan 15; 25(1):67-71. PubMed ID: 6249764
    [Abstract] [Full Text] [Related]

  • 7. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
    Dostal V, Fanta D, Reiss-Gutfreund RJ, Janisch H, Berger R.
    Wien Klin Wochenschr; 1977 Mar 18; 89(6):201-3. PubMed ID: 191994
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Correlation of human papilloma virus (HPV) and herpes simplex virus-2 (HSV-2)in the viral etiology of carcinoma of uterine cervix].
    Meng XJ.
    Zhonghua Zhong Liu Za Zhi; 1989 Mar 18; 11(2):108-10. PubMed ID: 2553361
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi.
    Chiphangwi JD.
    IARC Sci Publ; 1984 Mar 18; (63):465-70. PubMed ID: 6100279
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Etiological role of the herpes simplex virus in causing cervical cancer].
    Posevaia TA, Shubladze AK, Grigor'ev VV, Ugriumov EP, Kitsak VIa.
    Vopr Virusol; 1979 Mar 18; (6):611-5. PubMed ID: 230645
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.